Because outcome data at the usual daily dose of 12.5-25 mg are lacking, antihypertensive efficacy is paltry, and adherence is poor, HCTZ is an inappropriate first-line drug in hypertension. If a "thiazide-type" diuretic is indicated, either chlorthalidone or indapamide should be selected. Copyright Â© 2011 Elsevier Inc. 